» Articles » PMID: 19158210

Iron Deficiency and Child and Maternal Health

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2009 Jan 23
PMID 19158210
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Iron deficiency is most commonly found in women of reproductive age and infants worldwide, but the influence of maternal iron deficiency on infant development is underexplored.

Objective: The objective was to examine the relation between maternal iron status and mother-child interactions in a randomized, double-blind, intervention trial conducted in South Africa.

Design: Women were recruited into the study from a health clinic at 6-8 wk postpartum and were classified as either iron-deficient anemic (IDA) or iron-sufficient after blood analysis. IDA mothers received iron supplements of 125 mg FeSO(4) (IDA-Fe; n = 34) or placebo (IDA-PL; n = 30) daily from 10 wk to 9 mo postpartum. The control group (n = 31) consisted of iron-sufficient mothers. Free-play mother-child interaction sessions were videotaped in the clinic at 10 wk (n = 80) and 9 mo (n = 66) postpartum and coded per the Emotional Availability Scales (4 maternal scales: sensitivity, structuring, nonintrusiveness, and nonhostility; 2 infant scales: responsiveness and involvement).

Results: At 10 wk, scores for maternal sensitivity and child responsiveness were significantly greater in the control group than in the IDA groups (P = 0.028 and 0.009, respectively). At 9 mo, the control and IDA-Fe groups no longer differed. These 2 groups scored significantly better on the maternal sensitivity, structuring, and nonhostility scales and on the child responsiveness scale than did the IDA-PL group (P = 0.007-0.032), whose iron status remained low.

Conclusion: These data indicate that maternal iron deficiency negatively affects mother-child interactions and that iron supplementation protects against these negative effects.

Citing Articles

Developing Iron and Iodine Enrichment in Tomato Fruits to Meet Human Nutritional Needs.

Ikram N, Abdalla M, Muhling K Plants (Basel). 2024; 13(23).

PMID: 39683231 PMC: 11644362. DOI: 10.3390/plants13233438.


Treatment for women with postpartum iron deficiency anaemia.

Jensen M, Holm C, Jorgensen K, Schroll J Cochrane Database Syst Rev. 2024; 12:CD010861.

PMID: 39670550 PMC: 11639052. DOI: 10.1002/14651858.CD010861.pub3.


Implementing a Labor and Delivery Cell Salvage Protocol in Patients at Increased Risk of Hemorrhage: A Pilot Study.

Cabrera C, Tavella N, Goldberger C, Iwelumo C, Mitchell E, Lubell D Cureus. 2024; 16(11):e73334.

PMID: 39524169 PMC: 11549931. DOI: 10.7759/cureus.73334.


Non-invasive Hemoglobin Screening for Detection of Postpartum Anemia.

Das Mahapatra P, Mohakud N, Roy C, Rajagopal H, Sharma S Womens Health Rep (New Rochelle). 2024; 5(1):565-571.

PMID: 39206019 PMC: 11347867. DOI: 10.1089/whr.2024.0028.


Efficacy and safety of Ferrous iron on the prevention of Vascular cOgnitive impaiRment among patients with cerebral Infarction/TIA (FAVORITE): rationale and design of a multicentre randomised trial.

Jia Q, Lei P, Sun L, Jia W, Pan Y, Yuan B Stroke Vasc Neurol. 2024; 10(1):136-141.

PMID: 38789134 PMC: 11877433. DOI: 10.1136/svn-2023-002644.